sk&f 81297 has been researched along with n-methyl-3,4-methylenedioxyamphetamine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aguirre, N; Goñi-Allo, B; Ramos, M | 1 |
Bradbury, S; Gittings, D; Schenk, S | 1 |
2 other study(ies) available for sk&f 81297 and n-methyl-3,4-methylenedioxyamphetamine
Article | Year |
---|---|
Administration of SCH 23390 into the medial prefrontal cortex blocks the expression of MDMA-induced behavioral sensitization in rats: an effect mediated by 5-HT2C receptor stimulation and not by D1 receptor blockade.
Topics: Animals; Behavior, Animal; Benzazepines; Dopamine Antagonists; Hallucinogens; Male; Microinjections; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Prefrontal Cortex; Pyrazines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2C; Receptors, Dopamine D1; Serotonin Receptor Agonists; Spiro Compounds; Sulfonamides | 2005 |
Repeated exposure to MDMA and amphetamine: sensitization, cross-sensitization, and response to dopamine D₁- and D₂-like agonists.
Topics: Animals; Benzazepines; Dextroamphetamine; Dose-Response Relationship, Drug; Male; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2 | 2012 |